Beyond Barriers

A novel technology platform
for the delivery of therapeutics
across biological barriers

TECHNOLOGY INVESTORS
Gate2Brain

The solution

Gate2Brain
Technology

Gate2Brain (G2B) uses a novel technology platform for the delivery of therapeutics. Our platform is based on three families of peptide shuttles that improve the biopharmaceutical properties of cargoes such as small molecules, peptides, nanoparticles, proteins and antibodies in vitro and in vivo when conjugated to them.

The G2B technology platform is applicable to therapeutic areas in which biological barriers hinder the delivery and activity of drugs.

Read more

About us

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We pursue our goals using a radically innovative peptide-based patented technology platform.

Read more
Link to: Technology
Technology

Gate2Brain (G2B) has a proprietary novel technology platform for the delivery of therapeutics across biological barriers.

Link to: Pipeline-Proof of Concept
Pipeline and Therapeutic Proof of Concept

G2B-002, the first therapeutic proof of concept of our technology platform, is aimed mainly at the treatment of rare pediatric solid tumors.

Link to: Investors
Investors

A strong network of investors ensures funding to achieve our goals.

Medicines beyond barriers

We go beyond physiological and disease barriers, as our portfolio of peptide shuttles cover barriers such as the blood-brain,
blood-retinal, skin and tumor barriers. We go beyond economic barriers, such as the lack of investment for the development of pediatric drugs. We go beyond societal barriers to provide medicines for everyone, everywhere.

Clinical Focus

Therapeutic
Proof of Concept

Our G2B therapeutic-peptide shuttle conjugates carry the drug cargo candidates to the target site in which the disease arises. G2B-002, our flagship product and proof of concept of the technology, offers a new therapeutic approach with improved biopharmaceutical properties and potent activity against rare pediatric cancers.

Our objective is for G2B-002 to reach Phase 1 clinical trials and thus have a high social impact focused on the unmet medical needs of oncology, pediatric and rare diseases.

G2B-002 shows potent preclinical activity for rare pediatric cancer indications such as pediatric high-grade gliomas, DIPG, Ewing sarcoma, rhabdomyosarcoma and neuroblastoma.

READ MORE
Gate2Brain

News & Media

Welcome to our news section, which provides a selection of our coverage in the media, industry, latest developments, plus videos, and more.

LSX World Congress

Gate2Brain wil be attending LSX WORLD CONGRESS where the biotech, healthtech and medtech industry’s…
Read more

Hospital Connection

On Wednesday, Helena Castillo Ecija PhD, MBA, our Preclinical and Clinical Project Manager, attended…
Read more

Marina Plaza – Meet the Team

, ,
https://youtu.be/CscybYeYWEE?si=gA5l5cjToqGW-wwv  
Read more

Meritxell Teixidó, one of the 20 recipients of the Jump Startup for Women in Deeptech program

Foment and the Consulate General of the United States presented the 20 entrepreneurs selected with the…
Read more

Research & Innovation Week Brussels

,
Since yesterday, Gate2Brain has been participating in Research & Innovation (R&I) Week, a flagship…
Read more

Gate2Brain, winner of the Senén Vilaró Award, explains its innovative technology

,
In light of receiving the Senén Vilaró Award, the University of Barcelona has crafted this brief video…
Read more

CataloniaBio HealthTech Gala 2024

,
Last night, Gate2Brain had the honor of attending the CataloniaBio HealthTech Gala with entrepreneurs,…
Read more

4YFN 2024

It has been a series of intense and enriching days at 4YFN, within the Catalonia Health Innovation Ecosystem…
Read more

Ricard Casanovas – Meet the Advisory Board!

,
We are continuing to introduce the remarkable individuals who make up Gate2Brain’s external advisory…
Read more

XVth SPLC-CRS Conference on Controlled Drug Delivery

Last week, Gate2Brain had the privilege of attending the XVth SPLC-CRS Conference on Controlled Drug…
Read more
NEWS & MEDIA
1
2
Gate2Brain
1

Making therapies a reality for patients by addressing unmet medical needs.

2

Improving patients’ quality of life using a technology that provides superior drug transport efficacy.

Go Beyond Barriers & Contact Us

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Gate2Brain
Gate2Brain
Gate2Brain
Gate2Brain
Gate2Brain
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social